Navigation Links
Homeopathic Pharmacists' Association Highlights the Extraordinary Safety Record of Homeopathic Medicines
Date:6/19/2009

SANTA ROSA, Calif., June 19 /PRNewswire/ -- The American Association of Homeopathic Pharmacists (AAHP) acknowledges the U.S. Food and Drug Administration's (FDA) action to protect the public by sending a Warning Letter to Matrixx Innovations, Inc., in connection with that company's sale of Zicam intranasal zinc medications. According to the FDA, these intranasal zinc products have been associated with a number of cases of loss of smell. Matrixx now has an opportunity to respond to the FDA's concerns about the safety of its products.

However, the AAHP feels it is necessary to clarify misleading issues raised in a nationally syndicated Associated Press article, "Zicam Not Alone in Side Effect Reports," which questions the safety of homeopathic medicines in general. Consumers and healthcare professionals alike should be assured that the FDA's action in regard to certain Zicam products does not apply to this class of drugs as a whole. Rather, the FDA's advisory relates only to the nasal application of a specific zinc product.

Homeopathic medications are regulated by the FDA and have been used safely in the United States since before the passage of the 1938 federal Food, Drug, and Cosmetic Act. Homeopathic medicines have an extraordinary record of safety. The FDA's Compliance Policy Guide (CPG 7132.15) "Conditions Under Which Homeopathic Drugs May be Marketed" has been an effective and workable way to regulate homeopathic drugs since 1988 and, as shown by the FDA's action on June 16, it allows the FDA to take action when action is required to protect the public.

To learn more about the regulatory process and the association's work to better the understanding and appreciation of homeopathic medicines by both professionals and consumers, visit www.homeopathicpharmacy.org.

About the AAHP

Founded in 1923,
'/>"/>

SOURCE American Association of Homeopathic Pharmacists
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. After Infant Gripe Water Recall Scare, Homeopathic Medicine Offers Safe Alternative
2. The Homeopathic Revolution
3. Hylands Homeopathic Medicine Offers Parents Safe, All-Natural Option to Alleviate the Symptoms of Colds
4. Hylands Inc. Reports More Consumers Turn to Homeopathic Medicines to Fight Illness at Home
5. Homeopathic First Aid Kit: Solutions for Summers Little Bummers
6. Argentyn 23(R) Homeopathic First Aid Gel - Another Worlds First by Natural-Immunogenics Corp. for Healthcare Professionals
7. ADD-care -- A Natural, Homeopathic Alternative Reducing Symptoms Related to Attention Deficit Disorder
8. Homeopathic medicines: Can they help relieve side-effects of cancer therapy?
9. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
10. CVS Caremark Celebrates American Pharmacists Month by Thanking Its 20,000 Pharmacists
11. Maryland Pharmacists Urge House Majority Leader Hoyer to Put Patients First
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... ... a novel catheter that was developed for targeted delivery of fluids to selected ... being treated at Florida Hospital Tampa with the device that provides direct, local ...
(Date:7/31/2015)... ... 31, 2015 , ... Ticket Down is a reputable source of authentic ... Soccer Team will face the Australia Women's National Team in two separate friendly contests. ... in Detroit and the second match will occur in Birmingham, Alabama at Legion Field. ...
(Date:7/31/2015)... ... July 31, 2015 , ... Indosoft, Inc., is pleased to ... Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for Asterisk-based call ... display logic shows the script components to the agent only when wanted, and allows ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... a contributor for LeadingAge’s Center for Aging Services Technologies (CAST) Medication Management Technologies ... long-term and post-acute care providers understand the benefits of using medication management ...
(Date:7/31/2015)... Metamora, Michigan (PRWEB) , ... July 31, 2015 ... ... 100th baby at Beaumont Hospital's Karmanos Center for Natural Birth . ... mothers looking for a safe natural childbirth experience. With nurses and caregivers that ...
Breaking Medicine News(10 mins):Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 2Health News:LeadingAge Selects Eldermark Case Study to Highlight Medication Error Reduction Results 3
... Law Requires Certification for Pharmacy Techs, 91% ... Support Standards in Every ... today by the,Pharmacy Technician Certification Board (PTCB) shows that Americans ... prepare prescriptions in pharmacies. The poll results,released today at the ...
... As companies transform their,call centers into service-to-sales operations, ... while maintaining a customer service,function. Because they play ... is one of the key factors behind a ... leaders recommend reducing spans of control by as,much ...
... Are you taking the proper steps,to ward off colds ... so, you could,win a trip to Orlando. The Florida ... healthy this season with the Stay Well. Play,Well. Florida ... should submit a 300-word essay describing their,best kept secrets ...
... State University has received a $5.7 million federal grant ... continue the development of community partnerships that strengthen families ... problems. , The new award will support PROSPER ... additional five years. The total award to Penn State ...
... panel to add it to list of ,probable, causes of ... on the night shifts at bars, convenience stores, hospitals and ... cancer. , That,s the conclusion of an international group of ... official list of "probable" carcinogens. , A team of scientists ...
... 5 Allos,Therapeutics, Inc. (Nasdaq: ALTH ), ... of small molecule therapeutics for,the treatment of cancer, ... will participate on the "Better Drugs & Novel ... Capital Markets Healthcare Conference in New,York., The ...
Cached Medicine News:Health News:Survey Shows Broad Support Among Americans for Pharmacy Technician Certification 2Health News:Managing the Service-to-Sales Cultural Transformation - Complimentary Excerpt Available from Best Practices 2Health News:Escape the Cold and Flu Season With a Free Vacation to the Sunshine State 2Health News:PSU $5.7 million grant to help families and youth avoid substance abuse, behavior problems 2Health News:Night Shift Work May Heighten Risk for Cancer 2Health News:Night Shift Work May Heighten Risk for Cancer 3Health News:Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference 2
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
(Date:7/30/2015)... July 30, 2015 Eisai Inc. announced today ... the United States , European Union and ... MHLW, respectively) for eribulin, for the treatment of patients ... prior chemotherapy for advanced or metastatic disease. ... a pivotal global Phase 3 clinical trial (Study 309), ...
(Date:7/30/2015)... Japan , July 30, 2015 ... of the study to fulfill the post-marketing commitment ... the Pan European Multi-Database Bladder Cancer Risk ... retrospective matched cohort study, conducted in four European ... HCI) with up to 10 years of follow-up. ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... DIEGO, March 21, 2012  Millennium Laboratories announced today ... the course for more responsible and ethical business ... outlines the principles to which Millennium adheres and ... in the pain management industry to adopt. ...
... encourages continuous electronic monitoring, including the use of both ... analgesia (PCA). According to the Institute ... knowledge exist today to prevent errors associated with use ... says , "The solutions are available. We know ...
Cached Medicine Technology:Millennium Laboratories Announces Laboratory Responsibility Pledge 2Millennium Laboratories Announces Laboratory Responsibility Pledge 3Physician-Patient Alliance for Health & Safety: Hospitals Need to Address PCA Pump Patient Safety 2
... IMMULITE 2500 is a high-throughput immunoassay ... ,of the IMMULITE 2000 with the important ... technology ,allows assays to be designed for ... times. ,This allows for critical assays such ...
... sulfate (DHEA-S) is the sulfate ester of ... enzymatic conversion of DHEA in adrenal and ... steroid secreted by the adrenal cortex, and ... biosynthesis. DHEA possesses relatively weak androgenic activity, ...
... DSL's unique DHEA-S-7kits ... antiserum targeted against the ... DHEA-S molecule, with no ... DHEA-S Saliva RIA has ...
... is based on the competition principle and ... DHEA-S present in the sample and a ... peroxidase compete for the binding sites of ... wells. After one hour incubation the microtiterplate ...
Medicine Products: